Complications Following Colonoscopy in a Nationwide Standard Cohort: A Retrospective Case-control Study
Ji‐Woo Kim(Health Insurance Review and Assessment Service), Dae Ryong Kang(Yonsei University), Yun Tae Kim(Yonsei University), Hyun‐Soo Kim(Yonsei University), Su Young Kim(Yonsei University), Geunu Park(Yonsei University), Jung Hye Choi(Hanyang University Guri Hospital), Jungkuk Lee(Yonsei University)
Cited by 5
Related Papers
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
|Journal of Clinical Oncology|2017|752
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
|The Lancet Oncology|2017|327
Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial
|Journal of Clinical Oncology|2018|313
Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables
|Blood|2019|175
Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
|Clinical Cancer Research|2018|161